Clinical analysis of ZhongTongAn combined with mecobalamin in treatment of primary trigeminal neuralgia in menopausal women

Jia-yin LIU,Min BI,Qi-lin MA
DOI: https://doi.org/10.3969/j.issn.1672-2973.2017.04.010
2017-01-01
Abstract:Objective:To investigate the clinical efficacy of ZhongTongAn combined with mecobalamin the treatment of menopausal women with primary trigeminal neuralgia.Methods:108 cases of primary trigeminal neuralgia women in the 45 to 60 years old were selected,randomly divided into two groups for double blind control study.Experimental group(54 case) was given ZhongTongAn combined with mecobalamin and the control group (54 case)was given carbamazepine.Visual analogue scale (VAS) was used to observe the pain of patients.During the 8 weeks of treatment,the improvement of pain,the remission of climacteric symptoms,and the adverse drug reactions occurred in each group were observed Long-term efficacy of the each treatment were statistics after one year follow-up.Results:Compared with before treatment and after treatment,both groups have significant decrease in visual analogue scale (VAS) values (P<0.05).There was no significant VAS difference between the experimental group and the control group in the same time point (P >0.05).Compare with the total efficiency between the two groups after one year,the total effective rate of the experimental group (90.74%) was obviously higher than the control groups (61.11%),P< 0.01.After eight weeks of treatment the experimental group has significantly improve in 16 factors of somatic symptoms,compared with before treatment was significantly different(P<0.01).In the control group,there was no obviously relief of somatic symptoms.Adverse reactions in the experimental group(3.70%) were lower than those in the control group(24.07%),the difference is significant (P<0.05).Conclusion:ZhongTongAn combined with Mecobalamin in the treatment of menopausal women with primary trigeminal neuralgia with significant pain relief effect.Its short-term efficacy has no obvious statistical difference with carbamazepine treatment and can effectively relieve menopausal symptoms,so that the long-term pain relief effect is significantly higher than carbamazepine,and less complications.
What problem does this paper attempt to address?